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Abstract
Introduction: The aim was to evaluate the postoperative morbidity and outcome
of palliative endoscopic resections for relief of infravesical obstruction in prostate
cancer patients with hormone deprivation therapy, and to investigate the added
value of bipolar technology over conventional monopolar resections.
Material and methods: A retrospective study was performed on 70 patients with
prostate cancer under hormone deprivation therapy undergoing 75 endoscopic
procedures, by either monopolar or bipolar technology, between August 2005
and March 2009 at a single institution. The analysis used outpatient, inpatient,
and operative records, and observations of electrolyte changes in the serum,
postoperative morbidity, and the overall results of palliative endoscopic
resections. Preoperative cancer stages and grades were compared with the
pathological findings after surgery. Postoperative outcome and complications
of conventional monopolar and bipolar technology were compared.
Results: Over a period of 44 months, 34 conventional monopolar resections were
performed in 32 patients and 41 bipolar resections in 38 patients. Patients’
profiles regarding age, initial cancer stage and grade, resection weight, resection
speed, catheterization time, and hospital stay were similar in both groups. No
statistically significant difference was observed in sodium drop (p = 0.802), clot
retention (p = 0.565), or urinary retention (p = 0.292). The overall success rate
in relieving obstruction leading to spontaneous voiding was 77%. While 38% of
the patients had a high grade tumour at diagnosis, 79% were found to be high
grade after the endoscopic resection (p < 0.0001).
Conclusions: Palliative endoscopic transurethral resection is an acceptable and safe
adjunctive surgical treatment for voiding disorders in prostate cancer patients. Bipolar
technology offers no substantial benefit over conventional monopolar technology.
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Introduction
Monopolar transurethral resection of the prostate (TURP) is the gold
standard for the operative management of benign prostatic hyperplasia
(BPH) [1].
New techniques must be compared with the known efficacy of
monopolar TURP [2]. The risk of complications such as transurethral
resection (TUR) syndrome, bleeding, and clot retention associated with
conventional monopolar resections discourages some patients from
choosing an endoscopic procedure.
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Bipolar resection of the prostate is based on
a slightly different technological concept. By
incorporating both the active and return poles on
the same electrode [3], a conductive fluid medium
(normal saline) instead of the conventional
nonconductive irrigation fluid (glycine, sorbitol, and
mannitol) can be used.
The peri- and postoperative morbidity as well as
the final outcome of bipolar resections with the
Gyrus PlasmaKinetic and the Olympus TURIS
systems was evaluated in several randomized
controlled trials [4]. All trials supported the
conclusion that bipolar technology provides
a similar clinical efficacy compared to that of
monopolar transurethral resection of the prostate
[4]. The lower risk of peri- and postoperative
morbidity regarding TUR syndrome and clot
retention however does favour the bipolar
technology [5].
We retrospectively evaluated this peri- and
postoperative morbidity using both techniques in
patients with urinary obstruction due to prostate
cancer.
Material and methods
A retrospective analysis of 75 endoscopic
procedures in 70 patients for relief of obstructive
voiding difficulties and retention due to prostate
cancer was performed at a single university
institution between August 2005 and March 2009.
Outpatient records, inpatient charts, and operative
reports were reviewed.
Electrolyte changes, postoperative complications,
and clinical outcome were selected as data points
of special interest in order to compare the two
slightly different pieces of operative equipment, i.e.
the monopolar technique (TURP) and bipolar
technique (TURIS).
All palliative endoscopic resections were
performed by two staff urologists, both familiar
with the two types of equipment. A standard
Olympus resectoscope and an Olympus UES-40
SurgMaster electrical current generator were used
for both techniques. Monopolar TURP was carried
out with a standard 24 Fr resectoscope and
standard loops using 175 W cutting power and 75 W
coagulation power. Bipolar TURIS was performed
using a 24 Fr resectoscope with the bipolar
electrode set at 270 W for cutting and 75 W for
coagulation. All procedures were performed with
intermittent glycine 5% (monopolar TURP) or saline
0.9% (bipolar TURIS) irrigation using general or
spinal anaesthesia. An average amount of 
12 litres/procedure was used.
Both urologists used the same resection
technique. Palliative resection was defined as
a limited resection to create a channel permitting
better urinary flow. In contrast with standard
endoscopic resection for BPH, resection to the depth
of the prostatic capsule was not attempted. All
resected tissue was weighed and submitted to the
pathologist for review. At the end of the procedure,
a 22 Fr 3-way Foley catheter with a closed drainage
system was inserted. All patients were treated
postoperatively with continuous saline bladder
irrigation until bleeding ended. After discharge,
patients were reassessed at three-month intervals.
All statistical tests performed were two-sided
and at the 5% level of performance. The two groups
were compared using the independent T-test. The
incidence of complications such as TUR syndrome,
clot retention, and urinary retention were
determined by Fisher’s exact test. The p-values
obtained were similar to the χ2 test with continuity
correction. SPSS version 17.0 was used to perform
the tests.
Results
A total of 70 patients underwent 75 endoscopic
procedures between August 2005 and March 2009.
Their mean age was 76 ±9 years (range 61 to 
93 years). The mean time from cancer diagnosis to
endoscopic resection was 56.7 ±52.5 months (range
3 to 210 months). The initial oncological parameters
are listed in Table I. In 68 of the 70 patients, the
initial diagnosis of prostate cancer was made in our
institution. T1 prostate cancer was found in 18%,
T2 prostate cancer in 22%, T3 prostate cancer 
in 53%, and T4 prostate cancer in 7%. Regarding
initial grading, 12% had well-differentiated, 50%
moderately differentiated, and 38% poorly
differentiated prostate cancer. Twenty-two of the
68 men had metastatic disease as documented by
plain X-ray and bone scan at the time of diagnosis.
Variables Monopolar Bipolar Total
TURPT U RIS N (%)
N (%) N (%)
Stage
T1 6 (19) 6 (17) 12 (18)
T2 5 (16) 10 (28) 15 (22)
T3 19 (59) 17 (47) 36 (53)
T4 2 (6) 3 (8) 5 (7)
Grade
2-4 4 (17) 3 (9) 7 (12)
5-7 12 (50) 17 (50) 29 (50)
8-10 8 (33) 14 (41) 22 (38)
Bone  11 (34) 11 (31) 22 (32)
metastases
Table I. Initial oncological parameters
TURP – transurethral resection of prostate, TURIS – transurethral
resection of prostate in saline, N – number
Bipolar versus monopolar technique for palliative transurethral prostate resection782 Arch Med Sci 5, October / 2010
The initial treatments are listed in Table II. Of the
70 patients, 16 (23%) patients received external
beam radiation therapy. In 7 patients this was
combined with hormonal treatment with luteinizing
hormone-releasing hormone during 3 years. Forty-
four (63%) patients had hormonal treatment for
prostate cancer from the beginning (luteinizing
hormone-releasing hormone in 38 patients and
bilateral subcapsular orchiectomy in 6 patients). In
10 patients, active surveillance was preferred.
At the time of resection, all patients had urinary
retention while under hormonal treatment. PSA
values are listed in Table III. Thirty-four palliative
resections were carried out in 32 patients by
conventional monopolar technique. In 38 patients,
41 bipolar resections in saline were performed. 
Table IV compares the preoperative and perio  -
perative statistics. Average preoperative prostatic
volume measured by transrectal ultrasound was
58.6 ±16.5 g in the conventional monopolar group
and 51.0 ±16.8 g in the bipolar group. Table V shows
that a vast majority of patients had spinal
anaesthesia (91% in the conventional monopolar
group, 78% in the bipolar group). Of all perioperative
parameters, only longer resection time was
statistically significant in the bipolar group 
(40.0 ±15.2 min vs. 49.1 ±20.5 min) (P = 0.03).
However, after correction with respect to the weight
of resected prostatic tissue, no statistically
significant difference in resection speed between
the two groups was observed (0.4 ±0.3 g/min vs.
0.4 ±0.3 g/min). Tables VI and VII show the changes
in electrolytes before and after resection. No
statistically significant changes were observed in
haemoglobin, sodium, potassium, or chloride.
Postoperatively there were no cases of TUR
syndrome in either group (Table IX). The indwelling
catheter was removed after 1.6 ±0.9 days in the
conventional monopolar group and 2.0 ±2.5 days in
the bipolar group (p = 0.342) (Table IV).
Seven palliative resections (9.3%) were
complicated with postoperative clot retention, 2 in
the conventional monopolar group and 5 in the
bipolar resection group (p = 0.565) (Table IX).
Palliative endoscopic resection was successful
in 77% of the patients. Urinary retention occurred
after 5 conventional monopolar resections (15%)
and 11 bipolar resections (27%) (p = 0.292). A long-
term indwelling catheter was necessary for 16
patients (23%) (Table IX).
Patients were discharged from the hospital after
respectively 4.6 ±2.2 days in the conventional and
5.8 ±4.6 days in the bipolar group (Table IV).
Postoperative pathological evaluation was
available in 66 (94.4%) patients. In 6 procedures
there was only benign prostate tissue in the
resected parts. Cancer was found in 65 procedures
(62 patients) (Table VIII), well-differentiated in 3%
Variables Monopolar Bipolar Total
TURPT U RIS N (%)
N (%) N (%)
Active surveillance 5 (16) 5 (13) 10 (14)
Radiotherapy 5 (16) 4 (11) 9 (13)
Radiotherapy and  2 (6) 5 (13) 7 (10)
3 years hormonal 
treatment
Hormonal treatment 20 (62) 24 (63) 44 (63)
Table II. Initial therapeutic approach to prostate
cancer
TURP – transurethral resection of prostate, TURIS – transurethral
resection of prostate in saline, N – number
Variables Monopolar  Bipolar 
TURP (± SD) TURIS (± SD)
PSA at diagnosis  70.35 (±118.43) 78.59 (±220.99)
[ng/ml]
PSA before  50.72 (±73.65) 128.16 (±274.80)
endoscopic resection 
PSA after  93.40 (±179.72) 71.92 (±142.80)
endoscopic resection 
Table III. PSA value at diagnosis, before and after
endoscopic resection
TURP – transurethral resection of prostate, TURIS – transurethral
resection of prostate in saline
Variables Monopolar TURPB ipolar TURIS p-value 95% confidence interval
mean (± SD) mean (± SD)
Age [years] 75.7 (±8.3) 75.6 (±8.8) 0.941  (–3.930, 4.230)
Prostate [ml] 58.6 (±16.5) 51.0 (±16.8) 0.517  (–33.976, 18.776)
Operative time [min] 40.0 (±15.2)  49.1 (±20.5) 0.032  (0.785, 17.374)
Resection weight [g] 16.86 (±10.6) 17.30 (±10.3) 0.858  (–5.361, 4.476)
Resection speed [g/min] 0.4 (±0.3) 0.4 (±0.3) 0.992  (–0.159, 0.157)
Catheterization time [days] 1.6 (±0.9) 2.0 (±2.5) 0.342  (–0.464, 1.321)
Hospital stay [days] 4.6 (±2.2) 5.8 (±4.6) 0.179 (–0.543, 2.855)
Table IV. Characteristics of two groups
TURP – transurethral resection of prostate, TURIS – transurethral resection of prostate in saline, SD – standard deviation
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(2 patients), moderately differentiated in 18% 
(11 patients) and poorly differentiated in 79% 
(49 patients). While 38% of the patients had a high
grade tumour at diagnosis, 79% were found to have
high grade prostate cancer at the time of the
resection.
Postoperative PSA analysis 3 months after sur  -
gery increased from a mean value of 50.72 ng/ml
before the surgery to a mean of 93.40 ng/ml in the
conventional monopolar group (Table III) (p = 0.372).
Over the same period in the bipolar group, there
was a PSA decline after surgery from 128.16 ng/ml
to 71.92 ng/ml (p = 0.350).
Discussion
Urinary retention is a common complication in
patients with locally advanced prostate cancer, with
an incidence of 13% to 20% [6-7]. The first step is
usually initiation of hormone deprivation treatment
in combination with an indwelling catheter [8].
Ultrasonic volume determinations in patients with
prostate cancer treated by hormonal deprivation
therapy showed a 50% reduction of the gland size
in the first month [9], continuing for nine months
after orchiectomy. Fleischmann and Catalona
reported a 68% response rate after hormonal
treatment for urinary retention in 35 patients with
advanced prostate cancer [10]. Unfortunately, an
indwelling catheter was necessary for 21 to 60 days
in 46% of the patients. Thomas et al. achieved an
83% success rate in 12 patients after 1 month [8].
Hormonal deprivation therapy is not limited to
orchiectomy. Varenhorst and Alund were successful
in relieving urethral obstruction by carcinoma of the
prostate in 65% of patients treated by orchiectomy,
cyproterone acetate, or oestrogens [11].
Hormonally deprived patients with acute or
persisting urinary retention are initially helped with
a transurethral or suprapubic bladder catheter. Since
long-term catheter drainage is hazardous, patients
who are fit for surgery are considered ideal
candidates for a palliative endoscopic prostate
resection. In this study, all patients were already on
hormone deprivation therapy when the urinary
retention occurred.
Palliative or channel TUR has the advantage of
enabling restored micturition but is not free from
complications such as stress incontinence and rapid
regrowth of obstructive prostate cancer requiring
Variables Monopolar Bipolar
TURP, N (%) TURIS, N (%)
Spinal anaesthesia 32 (91) 32 (78)
General anaesthesia 3 (9) 9 (22)
Table V. Anaesthesia
TURP – transurethral resection of prostate, TURIS – transurethral
resection of prostate in saline, N – number
Variables Preoperation, mean (± SD) Postoperation, mean (± SD) Difference
Monopolar TURP
Haemoglobin [mg/dl] 13.1 (±1.9) 11.9 (±1.7) –1.2
Sodium [mmol/l] 140.9 (±3.2) 139.2 (±2.7) –1.7
Potassium [mmol/l] 4.2 (±0.5) 4.1 (±0.4) –0.1
Chloride [mmol/l] 104.7 (±3.1) 105.1 (±3.2) +0.5
Bipolar TURIS
Haemoglobin [mg/dl] 12.8 (±2.0)  11.6 (±2.1) –1.3
Sodium [mmol/l] 141.9 (±3.0) 140.0 (±2.9) –1.9
Potassium [mmol/l] 4.1 (±0.4) 4.0 (±0.4) –0.1
Chloride [mmol/l] 105.1 (±2.9) 105.5 (±2.9) +0.4
Table VI. Summary of laboratory results
TURP – transurethral resection of prostate, TURIS – transurethral resection of prostate in saline, SD – standard deviation
Variables Monopolar TURPB ipolar TURIS p-value 95% confidence interval
mean (± SD) mean (± SD)
Haemoglobin [mg/dl] –1.2 (±0.9) –1.3 (±1.3) 0.606 (–0.629, 0.369)
Sodium [mmol/l] –1.7 (±3.1) –1.9 (±2.6) 0.802 (–1.491, 1.156)
Potassium [mmol/l] –0.1 (±0.4) –0.1 (±0.3) 0.331 (–0.086, 0.252)
Chloride [mmol/l] 0.5 (±2.7) 0.4 (±2.5) 0.895 (–1.288, 1.127)
Table VII. Chemical and haematological parameters
TURP – transurethral resection of prostate, TURIS – transurethral resection of prostate in saline, SD – standard deviation
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repeated surgery [12]. Mazur and Thompson report
a success rate of 79% [12]. In our study a success
rate of 77% was achieved. Palliative endoscopic
resection failed in 16 patients (23%), demanding
a long-term suprapubic or transurethral catheter
as a final solution.
Our re-operation rate was 6%. A factor in re-
intervention was a reoccurring obstruction due to
ongoing local tumour progression. Crain et al.
reported 29% of patients requiring additional
procedures [13], including surgical intervention for
haemorrhage and clot retention. Our incidence of
clot retention was 9.3%, but all cases could be
managed conservatively.
A potential drawback of palliative endoscopic
transurethral resection of a malignant gland is that
this is technically more difficult. The prostatic
urethra may be rigid and both the verumontanum
and external sphincter hard to identify. This leads
to a higher risk of incontinence. External
radiotherapy that had been applied in some
patients causes radiation effects that may
contribute to the complication rate.
Palliative endoscopic resections have been
criticized by Engelhardt and Riedl [14], as resection
and venous propagation of tumour cells may
enhance further dissemination of the disease. Such
a possible negative impact on progression has been
demonstrated in several studies. Fadlon et al.
detected circulating prostate cancer cells in the
serum of patients after prostate manipulations [15].
Clinical observations in patients with high grade
cancer or progressive cancer showed higher
postoperative rates of metastasis [16-19]. Further  -
more, some survival benefit was observed when
palliative endoscopic resection was avoided [14].
Therefore, Hübner et al. promotes intra  prostatic
stenting in locally advanced prostate cancer and
urinary obstruction [20]. Our personal experience
with prostatic stenting is disappointing and
corresponds with the results and the high rates of
complications reported in the literature [21]. Our
goal in hormonal refractory prostate cancer patients
is for improved quality of life rather than for
quantity of months of survival.
Transurethral resection of the prostate with
conventional monopolar loops remains the gold
standard for treatment of symptomatic obstructive
prostatic hypertrophy [22]. The current passes from
the active electrode on the monopolar resectoscope
through the patient's body to the return plate. This
can provoke deep tissue heating, stimulation of
underlying nerves or muscles, burning wounds at
the site of the return electrode and malfunction of
cardiac pacemakers [23]. The risk of complications
such as bleeding and absorption of irrigation fluid
with possible TUR syndrome cannot be ignored.
With bipolar systems, one tries to counter the
problems associated with conventional monopolar
systems by allowing resection in an iso-osmotic
saline solution and obviating the use of a return
electrode applied to the skin because the active and
return electrode are placed on the same axis on the
resectoscope.
Many studies have reported the advantages and
disadvantages of bipolar resection in BPH patients
[24-33]. Our group compared the Olympus TURIS
device over conventional monopolar resections in
238 BPH patients [23]. In the bipolar resection group
there were only 4 clot retentions (3.4%) and no
occurrence of TUR syndrome. But staff members
as well as trainees needed more operative time
with the bipolar system. We do not discard the
importance of the learning curve, but prolonged
operative time was also related to specific TURIS
characteristics such as the size of the resection loop
and smaller endoscopes [33].
To date, no studies have analysed the
advantages and disadvantages of bipolar resection
in prostate cancer patients. Therefore, we re-
analysed our data retrospectively. Two important
factors were investigated. Did bipolar resection have
a positive influence on the electrolyte balance in
this older and debilitated patient group, and was
bipolar resection associated with less prostate
bleeding after the procedure?
In the present study we did not observe
statistically significant changes in the electrolyte
balances, although this advantage was clear in BPH
patients. Possible explanations for this are the
smaller study groups, the shorter operation times
Variables Monopolar Bipolar Total
TURPT U RIS N (%)
N (%) N (%)
Grade
2-4 1 (3) 1 (3) 2 (3)
5-7 8 (28) 3 (9) 11 (18)
8-10 20 (69) 29 (88) 49 (79)
Table VIII. Histological data after endoscopic resec  -
tion
TURP – transurethral resection of prostate, TURIS – transurethral
resection of prostate in saline, N – number
Variables Monopolar Bipolar p
TURPT U RIS
N (%) N (%)
TUR syndrome 0 (0) 0 (0) 1.000
Clot retention 2 (6) 5 (12) 0.565
Urinary retention 5 (15) 11 (27) 0.292
Table IX. Complications
TURP – transurethral resection of prostate, TURIS – transurethral
resection of prostate in saline, TUR – transurethral resection
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in patients with prostate cancer, and the fact that
in palliative resections one does not need to go as
close to the surgical capsule of the prostate
because the creation of a voiding channel is
sufficient.
Surprisingly, there was a 12% clot retention rate
in the bipolar resection group. However, this is not
a statistically significant difference from the
conventional monopolar group. Recent experimental
work by Qu et al. reported significantly better
haemostasis with the bipolar technique of the
Gyrus PlasmaKinetic system (Gyrus Medical Ltd,
UK) in an isolated normal saline perfused porcine
kidney [34]. The coagulation depth with bipolar
technology is sufficient to seal blood vessels of 
125 µm diameter, which is not possible with
monopolar devices. Such vessels are only present
in 0.1% of benign prostate hyperplastic tissue.
In the majority (79%) of patients undergoing
palliative endoscopic resection, the tumour was
pathologically upgraded. Potential explanations for
this phenomenon are grade progression with time,
effects of hormonal deprivation, and achievement
of a hormone refractory state. Civantos et al.
pointed out that prolonged hormonal deprivation
induces histological changes in prostate cancer that
may be incorrectly interpreted as high-grade
disease [35].
In conclusions, urethral obstruction by prostate
cancer is initially treated by hormonal deprivation
and drained by a suprapubic or urethral catheter.
Endoscopic resection is a valuable therapeutic
option when hormonal manipulation fails or when
there is hormone refractory disease. Effective relief
of the obstruction is possible with an acceptable
rate of procedure-related side effects. In this specific
setting, bipolar technology offers no substantial
benefit over conventional monopolar technology.
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